Los Angeles, — Targeted Medical Pharma, Inc. (OTCQB: TRGM) in conjunction with Amino Nutritionals LLC, today announced the consumer release of THERALEVE™ (www.theralevehealth.com) a patented amino acid based formula designed by pain management physicians to help the 100 million chronic pain sufferers in the United States, fight pain and inflammation without the dangerous side effects commonly associated with NSAIDs and opioids.
“Common pain medications do not address the nutritional needs of the nervous system and only target symptoms of pain. THERALEVE provides a specific blend of amino acids and nutrients that support the foundation of good health and address the underlying factors that cause pain,” said Dr. David Silver, Chief Medical Officer at Targeted Medical Pharma.
THERALEVE is the first dietary supplement specifically designed to support the nervous system health of chronic pain sufferers. Previously only available through physicians, the patented amino acid formula in THERALEVE has been recommended to chronic pain sufferers by physicians for over a decade, with over 26 million doses taken and no reported dangerous side effects.
THERALEVE is the only amino acid based dietary supplement to use Targeted Cellular Technology, a patented micro-nutrient delivery system that aids the absorption of the key ingredients required to revitalize nervous system function and support the natural anti-inflammatory and pain fighting processes of the body. THERALEVE supports healthy joint, muscle and nervous system function in the fight against pain and inflammation.*
About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. (OTCQB:TRGM) is a Los Angeles based biotechnology company that develops and manufactures amino acid based medical foods and dietary supplements featuring the patented Targeted Cellular Technology. The Company distributes these products to physicians, pharmacies, hospitals, patients, and consumers throughout the United States, Japan and China to effectively treat pain, obesity, hypertension, sleep and cognitive disorders without the serious side effects associated with many drug therapies.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
# # #